BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 17062862)

  • 1. Safety of trivalent inactivated influenza vaccine in children 6 to 23 months old.
    Hambidge SJ; Glanz JM; France EK; McClure D; Xu S; Yamasaki K; Jackson L; Mullooly JP; Zangwill KM; Marcy SM; Black SB; Lewis EM; Shinefield HR; Belongia E; Nordin J; Chen RT; Shay DK; Davis RL; DeStefano F;
    JAMA; 2006 Oct; 296(16):1990-7. PubMed ID: 17062862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of trivalent inactivated influenza vaccine in children aged 24 to 59 months in the vaccine safety datalink.
    Glanz JM; Newcomer SR; Hambidge SJ; Daley MF; Narwaney KJ; Xu S; Lee GM; Baggs J; Klein NP; Nordin JD; Naleway AL; Belongia EA; Weintraub ES
    Arch Pediatr Adolesc Med; 2011 Aug; 165(8):749-55. PubMed ID: 21810637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of the trivalent inactivated influenza vaccine among children: a population-based study.
    France EK; Glanz JM; Xu S; Davis RL; Black SB; Shinefield HR; Zangwill KM; Marcy SM; Mullooly JP; Jackson LA; Chen R
    Arch Pediatr Adolesc Med; 2004 Nov; 158(11):1031-6. PubMed ID: 15520339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Live attenuated influenza vaccine, trivalent, is safe in healthy children 18 months to 4 years, 5 to 9 years, and 10 to 18 years of age in a community-based, nonrandomized, open-label trial.
    Piedra PA; Gaglani MJ; Riggs M; Herschler G; Fewlass C; Watts M; Kozinetz C; Hessel C; Glezen WP
    Pediatrics; 2005 Sep; 116(3):e397-407. PubMed ID: 16140685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal safety of trivalent inactivated influenza vaccine in pregnant women.
    Nordin JD; Kharbanda EO; Benitez GV; Nichol K; Lipkind H; Naleway A; Lee GM; Hambidge S; Shi W; Olsen A
    Obstet Gynecol; 2013 Mar; 121(3):519-525. PubMed ID: 23635613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compliance with the recommendations for 2 doses of trivalent inactivated influenza vaccine in children less than 9 years of age receiving influenza vaccine for the first time: a Vaccine Safety Datalink study.
    Jackson LA; Neuzil KM; Baggs J; Davis RL; Black S; Yamasaki KM; Belongia E; Zangwill KM; Mullooly J; Nordin J; Marcy SM; DeStefano F
    Pediatrics; 2006 Nov; 118(5):2032-7. PubMed ID: 17079576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors that may explain observed associations between trivalent influenza vaccination and gastrointestinal illness in young children.
    Newcomer SR; Hambidge SJ; McClure DL; Daley MF; Klein NP; Glanz JM
    Vaccine; 2013 Aug; 31(37):3894-8. PubMed ID: 23831326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signal identification and evaluation for risk of febrile seizures in children following trivalent inactivated influenza vaccine in the Vaccine Safety Datalink Project, 2010-2011.
    Tse A; Tseng HF; Greene SK; Vellozzi C; Lee GM;
    Vaccine; 2012 Mar; 30(11):2024-31. PubMed ID: 22361304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of pneumococcal conjugate vaccine in infants by maternal influenza vaccination status.
    van Santen KL; Bednarczyk RA; Adjaye-Gbewonyo D; Orenstein WA; Davis R; Omer SB
    Pediatr Infect Dis J; 2013 Nov; 32(11):1180-4. PubMed ID: 23856786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.
    Englund JA; Walter EB; Gbadebo A; Monto AS; Zhu Y; Neuzil KM
    Pediatrics; 2006 Sep; 118(3):e579-85. PubMed ID: 16950949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trivalent inactivated influenza vaccine is not associated with sickle cell crises in children.
    Hambidge SJ; Ross C; Glanz J; McClure D; Daley MF; Xu S; Shoup JA; Narwaney K; Baggs J; Weintraub E;
    Pediatrics; 2012 Jan; 129(1):e54-9. PubMed ID: 22157132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
    Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children.
    Piedra PA; Gaglani MJ; Kozinetz CA; Herschler GB; Fewlass C; Harvey D; Zimmerman N; Glezen WP
    Pediatrics; 2007 Sep; 120(3):e553-64. PubMed ID: 17698577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivated influenza vaccine during pregnancy and risks for adverse obstetric events.
    Kharbanda EO; Vazquez-Benitez G; Lipkind H; Naleway A; Lee G; Nordin JD;
    Obstet Gynecol; 2013 Sep; 122(3):659-67. PubMed ID: 23921876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse events after inactivated influenza vaccination among children less than 2 years of age: analysis of reports from the vaccine adverse event reporting system, 1990-2003.
    McMahon AW; Iskander J; Haber P; Chang S; Woo EJ; Braun MM; Ball R
    Pediatrics; 2005 Feb; 115(2):453-60. PubMed ID: 15687455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of cold-adapted live attenuated influenza vaccine in a large cohort of children and adolescents.
    Bergen R; Black S; Shinefield H; Lewis E; Ray P; Hansen J; Walker R; Hessel C; Cordova J; Mendelman PM
    Pediatr Infect Dis J; 2004 Feb; 23(2):138-44. PubMed ID: 14872180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Administration of inactivated trivalent influenza vaccine to parents of high-risk infants in the neonatal intensive care unit.
    Shah SI; Caprio M; Hendricks-Munoz K
    Pediatrics; 2007 Sep; 120(3):e617-21. PubMed ID: 17766502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomized controlled trial.
    Hoberman A; Greenberg DP; Paradise JL; Rockette HE; Lave JR; Kearney DH; Colborn DK; Kurs-Lasky M; Haralam MA; Byers CJ; Zoffel LM; Fabian IA; Bernard BS; Kerr JD
    JAMA; 2003 Sep; 290(12):1608-16. PubMed ID: 14506120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monovalent H1N1 influenza vaccine safety in pregnant women, risks for acute adverse events.
    Nordin JD; Kharbanda EO; Vazquez-Benitez G; Lipkind H; Lee GM; Naleway AL
    Vaccine; 2014 Sep; 32(39):4985-92. PubMed ID: 25045808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Live attenuated versus inactivated influenza vaccine in infants and young children.
    Belshe RB; Edwards KM; Vesikari T; Black SV; Walker RE; Hultquist M; Kemble G; Connor EM;
    N Engl J Med; 2007 Feb; 356(7):685-96. PubMed ID: 17301299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.